Skip to search boxSkip to navigationSkip to main content

Autoantibodies Against Ubiquitous and Confined Antigens in Patients With Ocular, Neuro-Ophthalmic and Congenital Cerebral Toxoplasmosis

  • Monica Goldberg-Murowe, f(Author)
    ,
  • Carlos Cedillo-Peláeze(Author)
    ,
  • Luz Elena Concha-del-Ríod(Author)
    ,
  • Rashel Cheja-Kalbd(Author)
    ,
  • María José Salgar-Henaod(Author)
    ,
  • Eduardo Orozco-Velascod(Author)
Research Output: Contribution to journal Article Peer-review

Open access

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Article number

606963

Journal (Volume, Issue Number)

Frontiers in Immunology (Volume 12)

Publication milestones

  • Published - 12/05/2021

Publication status

Published - 12/05/2021

External Publication IDs

  • Scopus: 85107022790
  • PubMed: 34054794

Abstract

Toxoplasma gondii infection can trigger autoreactivity by different mechanisms. In the case of ocular toxoplasmosis, disruption of the blood-retinal barrier may cause exposure of confined retinal antigens such as recoverin. Besides, cross-reactivity can be induced by molecular mimicry of parasite antigens like HSP70, which shares 76% identity with the human ortholog. Autoreactivity can be a determining factor of clinical manifestations in the eye and in the central nervous system. We performed a prospective observational study to determine the presence of autoantibodies against recoverin and HSP70 by indirect ELISA in the serum of 65 patients with ocular, neuro-ophthalmic and congenital cerebral toxoplasmosis. We found systemic autoantibodies against recoverin and HSP70 in 33.8% and 15.6% of individuals, respectively. The presence of autoantibodies in cases of OT may be related to the severity of clinical manifestations, while in cases with CNS involvement they may have a protective role. Unexpectedly, anti-recoverin antibodies were found in patients with cerebral involvement, without ocular toxoplasmosis; therefore, we analyzed and proved cross-reactivity between recoverin and a brain antigen, hippocalcin, so the immunological phenomenon occurring in one immune-privileged organ (e.g. the central nervous system) could affect the environment of another (egg. the eye).

Publication metrics

Metrics

SciVal
FWCI
0.25

PlumX, opens in new tab

Social media
41
Captures
28
5